» Articles » PMID: 17603844

T Cell Dysfunction by Hepatitis C Virus Core Protein Involves PD-1/PDL-1 Signaling

Overview
Journal Viral Immunol
Date 2007 Jul 3
PMID 17603844
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Reports have shown that a negative T cell costimulatory pathway mediated by PD-1 (programmed death-1) and PDL-1 (programmed death ligand-1) is associated with T cell exhaustion and persistent viral infection. Persistent hepatitis C virus (HCV) infection in humans is also characterized by impaired T lymphocyte function, but the role of the PD-1 and PDL-1 pathway in HCV infection is unknown. Here we report that T cells isolated from chronically HCV-infected patients express significantly higher levels of PD-1 when compared with healthy donors. In addition, PD-1 and PDL-1 expression is upregulated on healthy donor T cells exposed to HCV core, a nucleocapsid protein that is immunosuppressive; upregulation of PD-1 is mediated through interaction of HCV core with the complement receptor, gC1qR. Importantly, T cell functions that are dysregulated by HCV core, including T cell activation, proliferation, and apoptosis, can be restored by blocking PD-1 and PDL-1 engagement. Our results indicate that HCV core can upregulate a key negative T cell signaling pathway associated with viral persistence and highly expressed on the T cells of persistently infected individuals. This upregulation of the PD-1 and PDL-1 pathway in humans represents a novel and perhaps common mechanism by which a virus usurps host machinery to facilitate persistence.

Citing Articles

Emerging Role of PD-1/PD-L1 Inhibitors in Chronic Liver Diseases.

Singh V, Khurana A, Allawadhi P, Banothu A, Bharani K, Weiskirchen R Front Pharmacol. 2022; 12:790963.

PMID: 35002724 PMC: 8733625. DOI: 10.3389/fphar.2021.790963.


Occult Infection with Hepatitis C Virus: Looking for Clear-Cut Boundaries and Methodological Consensus.

Wroblewska A, Bielawski K, Sikorska K J Clin Med. 2021; 10(24).

PMID: 34945170 PMC: 8707082. DOI: 10.3390/jcm10245874.


PD-1 Blockade Restores the Proliferation of Peripheral Blood Lymphocyte and Inhibits Lymphocyte Apoptosis in a BALB/c Mouse Model of CP BVDV Acute Infection.

Liu Y, Wu C, Chen N, Li Y, Fan C, Zhao S Front Immunol. 2021; 12:727254.

PMID: 34552590 PMC: 8450576. DOI: 10.3389/fimmu.2021.727254.


Hepatocellular Carcinoma-The Influence of Immunoanatomy and the Role of Immunotherapy.

Patel K, Lamm R, Altshuler P, Dang H, Shah A Int J Mol Sci. 2020; 21(18).

PMID: 32942580 PMC: 7555667. DOI: 10.3390/ijms21186757.


PD-1 Blockade and TLR7 Activation Lack Therapeutic Benefit in Chronic Simian Immunodeficiency Virus-Infected Macaques on Antiretroviral Therapy.

Bekerman E, Hesselgesser J, Carr B, Nagel M, Hung M, Wang A Antimicrob Agents Chemother. 2019; 63(11).

PMID: 31501143 PMC: 6811450. DOI: 10.1128/AAC.01163-19.